Abstract
Cardiac hypertrophy can be divided as pathological hypertrophy and physiological hypertrophy. Unlike pathological hypertrophy, physiological hypertrophy is a beneficial adaptive response, which will not cause heart failure and sudden death and can protect adverse cardiac remodeling. Exercise training is widely known to cause physiological hypertrophy. The genomic basis of pathological hypertrophy and heart failure has been well-known and is well-reviewed. In this review, we will review the genomic profiles of physiological hypertrophy and also summarize genes and microRNAs responsible for exercise-induced physiological hypertrophy. With better understanding of physiological hypertrophy, manipulation of genes or miRNAs responsible for physiological hypertrophy will offer exciting avenues for treating heart failure.
Keywords: Exercise, Physiological hypertrophy, Genomics, MicroRNA
Current Genomics
Title:Exercise-induced Physiological Hypertrophy: Insights from Genomics
Volume: 16 Issue: 2
Author(s): Dongchao Lv, Qi Sun, Yuping Deng, Jiahong Xu, Huansen Huang and Junjie Xiao
Affiliation:
Keywords: Exercise, Physiological hypertrophy, Genomics, MicroRNA
Abstract: Cardiac hypertrophy can be divided as pathological hypertrophy and physiological hypertrophy. Unlike pathological hypertrophy, physiological hypertrophy is a beneficial adaptive response, which will not cause heart failure and sudden death and can protect adverse cardiac remodeling. Exercise training is widely known to cause physiological hypertrophy. The genomic basis of pathological hypertrophy and heart failure has been well-known and is well-reviewed. In this review, we will review the genomic profiles of physiological hypertrophy and also summarize genes and microRNAs responsible for exercise-induced physiological hypertrophy. With better understanding of physiological hypertrophy, manipulation of genes or miRNAs responsible for physiological hypertrophy will offer exciting avenues for treating heart failure.
Export Options
About this article
Cite this article as:
Lv Dongchao, Sun Qi, Deng Yuping, Xu Jiahong, Huang Huansen and Xiao Junjie, Exercise-induced Physiological Hypertrophy: Insights from Genomics, Current Genomics 2015; 16 (2) . https://dx.doi.org/10.2174/1389202916999150120153618
DOI https://dx.doi.org/10.2174/1389202916999150120153618 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mitochondrial Tolerance to Drugs and Toxic Agents in Ageing and Disease
Current Drug Targets Update on Cardiovascular Effects of Older and Newer Anti-diabetic Medications
Current Medicinal Chemistry Novel Carriers for Coenzyme Q10 Delivery
Current Drug Delivery Prader-Willi Syndrome: Genetics, Phenotype, and Management
Current Psychiatry Reviews PDE7-Selective and Dual Inhibitors: Advances in Chemical and Biological Research
Current Medicinal Chemistry Mitochondrial VDAC1: Function in Cell Life and Death and a Target for Cancer Therapy
Current Medicinal Chemistry Emerging Roles of Meis1 in Cardiac Regeneration, Stem Cells and Cancer
Current Drug Targets Severe Psychiatric Disorders in Mid-Life and Risk of Dementia in Late- Life (Age 65-84 Years): A Population Based Case-Control Study
Current Alzheimer Research Anti-Inflammatory Agents from Plants: Progress and Potential
Current Medicinal Chemistry Regulation of the Endoplasmic Reticulum Ca2+-Store in Cancer
Anti-Cancer Agents in Medicinal Chemistry Involvement of the Mitochondrial Benzodiazepine Receptor in Traumatic Brain Injury: Therapeutic Implications
CNS & Neurological Disorders - Drug Targets The Impact of Hypertension in Hemodialysis Patients
Current Hypertension Reviews The Effect of Non-Thermal Microwave-Treated Physiological Solution on Isolated Heart Muscle of Snail
Current Chemical Biology Oral Glucose-lowering Drugs and Cardiovascular Outcomes: From the Negative RECORD and ACCORD to Neutral TECOS and Promising EMPA-REG
Current Vascular Pharmacology Antioxidants in the Practice of Medicine; What Should the Clinician Know?
Cardiovascular & Hematological Disorders-Drug Targets Hemodynamic Assessment and In vivo Catabolism of Adenosine 5’-triphosphate in Doxorubicin or Isoproterenol-induced Cardiovascular Toxicity
Drug Metabolism Letters Single Molecule Techniques for Biomedicine and Pharmacology
Current Pharmaceutical Biotechnology Malignant Hypertension: A Rare Problem or is it Underdiagnosed?
Current Vascular Pharmacology Mineralocorticoid Receptor Antagonists in Primary Aldosteronism
Current Pharmaceutical Design Role of Lycopene in the Control of ROS-Mediated Cell Growth: Implications in Cancer Prevention
Current Medicinal Chemistry